Rosiglitazone once or twice daily improves glycemic control in patients with type 2 diabetes (T2D)

被引：0
|
作者：
Grunberger, G
Weston, WM
Patwardhan, R
Rappaport, EB
机构：
来源：
DIABETES | 1999年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0439
引用
收藏
页码：A102 / A102
页数：1
相关论文
共 50 条
  • [1] Rosiglitazone once or twice daily improves glycemic control in patients with type 2 diabetes
    Grunberger, G
    Weston, WM
    Patwardhan, R
    Rappaport, EB
    [J]. DIABETOLOGIA, 1999, 42 : A4 - A4
  • [2] Once- and twice-daily dosing with rosiglitazone improves glycemic control in patients with type 2 diabetes
    Phillips, LS
    Grunberger, G
    Miller, E
    Patwardhan, R
    Rappaport, EB
    Salzman, A
    [J]. DIABETES CARE, 2001, 24 (02) : 308 - 315
  • [3] Once- and twice-daily dosing with rosiglitazone improves glycemic control in patients with type 2 diabetes (vol 24, pg 308, 2001)
    Phillips, LS
    Grunberger, G
    Miller, E
    Patwardhan, R
    Rappaport, EB
    Salzman, A
    [J]. DIABETES CARE, 2001, 24 (05) : 973 - 973
  • [4] Switching from Twice-Daily Exenatide to Once-Daily Liraglutide Improves Glycemic Control in T2D on Oral Agents
    Buse, John
    Sesti, Giorgio
    Schmidt, Wolfgang E.
    Mon-Tanya, Eduard
    Chang, C. T.
    Xu, Y.
    Blonde, Lawrence
    Rosenstock, Julio
    [J]. DIABETES, 2009, 58 : A159 - A159
  • [5] Rosiglitazone (RSG) improves glycemic control in poorly controlled, insulin-treated type 2 diabetes (T2D)
    Raskin, P
    Dole, JF
    Rappaport, EB
    [J]. DIABETES, 1999, 48 : A94 - A94
  • [6] IDegLira Improves Glycemic Control in Japanese Patients with Type 2 Diabetes (T2D) Uncontrolled on Premixed Insulin Therapy
    Watada, Hirotaka
    Agner, Bue F.
    Doshi, Ankur
    Gron, Randi
    Ranthe, Mattis F.
    Billings, Liana K.
    [J]. DIABETES, 2019, 68
  • [7] Humalog® Mix25™ twice daily improves glycemic control compared to NPH twice daily in patients with type 2-diabetes
    Reviriego, J
    Herz, M
    Roach, P
    [J]. DIABETES, 2000, 49 : A363 - A364
  • [8] Humalog® Mix75/25™ twice daily improves glycemic control compared with NPH twice daily in patients with type 2 diabetes
    Malone, JK
    Sun, B
    Mattoo, V
    Demeter, R
    Frisby, D
    [J]. DIABETES, 2002, 51 : A474 - A474
  • [9] Switching to Once-Daily Liraglutide From Twice-Daily Exenatide Further Improves Glycemic Control in Patients With Type 2 Diabetes Using Oral Agents
    Buse, John B.
    Sesti, Giorgio
    Schmidt, Wolfgang E.
    Montanya, Eduard
    Chang, Cheng-Tao
    Xu, Yizhen
    Blonde, Lawrence
    Rosenstock, Julio
    [J]. DIABETES CARE, 2010, 33 (06) : 1300 - 1303
  • [10] Glycemic Control and Adherence to Basal Insulin Therapy in Taiwanese Patients with Type 2 Diabetes (T2D)
    Chien, Ming-Nan
    Chen, Yen-Ling
    Hung, Yi-Jen
    Wang, Shu-Yi
    Lu, Wen-Tsung
    Chen, Chih-Hung
    Lin, Ching-Ling
    Huang, Tze-Pao
    Tsai, Ming-Han
    Tseng, Wei-Kung
    Wu, Ta-Jen
    Ho, Cheng
    Lin, Wen-Yu
    Chen, Bill
    Chuang, Lee-Ming
    [J]. DIABETES, 2014, 63 : A600 - A600
12345